155 related articles for article (PubMed ID: 34849858)
1. Novel role of prostate cancer risk variant rs7247241 on PPP1R14A isoform transition through allelic TF binding and CpG methylation.
Tian Y; Soupir A; Liu Q; Wu L; Huang CC; Park JY; Wang L
Hum Mol Genet; 2022 May; 31(10):1610-1621. PubMed ID: 34849858
[TBL] [Abstract][Full Text] [Related]
2. Identification of Candidate mRNA Isoforms for Prostate Cancer-Risk SNPs Utilizing Iso-eQTL and sQTL Methods.
Moradi A; Sharma H; Sharma RD; Fernando A; Barrero RA; Batra J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293264
[TBL] [Abstract][Full Text] [Related]
3. Allele-specific DNA methylation reinforces PEAR1 enhancer activity.
Izzi B; Pistoni M; Cludts K; Akkor P; Lambrechts D; Verfaillie C; Verhamme P; Freson K; Hoylaerts MF
Blood; 2016 Aug; 128(7):1003-12. PubMed ID: 27313330
[TBL] [Abstract][Full Text] [Related]
4. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
Wu L; Yang Y; Guo X; Shu XO; Cai Q; Shu X; Li B; Tao R; Wu C; Nikas JB; Sun Y; Zhu J; Roobol MJ; Giles GG; Brenner H; John EM; Clements J; Grindedal EM; Park JY; Stanford JL; Kote-Jarai Z; Haiman CA; Eeles RA; Zheng W; Long J; ; ; ; ;
Nat Commun; 2020 Aug; 11(1):3905. PubMed ID: 32764609
[TBL] [Abstract][Full Text] [Related]
5. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
Samy MD; Yavorski JM; Mauro JA; Blanck G
Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
[TBL] [Abstract][Full Text] [Related]
6. A Genome-Wide mQTL Analysis in Human Adipose Tissue Identifies Genetic Variants Associated with DNA Methylation, Gene Expression and Metabolic Traits.
Volkov P; Olsson AH; Gillberg L; Jørgensen SW; Brøns C; Eriksson KF; Groop L; Jansson PA; Nilsson E; Rönn T; Vaag A; Ling C
PLoS One; 2016; 11(6):e0157776. PubMed ID: 27322064
[TBL] [Abstract][Full Text] [Related]
7. CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.
Desotelle J; Truong M; Ewald J; Weeratunga P; Yang B; Huang W; Jarrard D
J Urol; 2013 Jan; 189(1):329-35. PubMed ID: 23174249
[TBL] [Abstract][Full Text] [Related]
8. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
9. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
10. Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics.
Taqi MM; Bazov I; Watanabe H; Sheedy D; Harper C; Alkass K; Druid H; Wentzel P; Nyberg F; Yakovleva T; Bakalkin G
Addict Biol; 2011 Jul; 16(3):499-509. PubMed ID: 21521424
[TBL] [Abstract][Full Text] [Related]
11. Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.
Savio AJ; Bapat B
Epigenetics; 2017 Jun; 12(6):441-448. PubMed ID: 28304185
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
Xiao F; Zhang P; Wang Y; Tian Y; James M; Huang CC; Wang L; Wang L
Mol Carcinog; 2020 Jan; 59(1):45-55. PubMed ID: 31659808
[TBL] [Abstract][Full Text] [Related]
13. CTCF loss mediates unique DNA hypermethylation landscapes in human cancers.
Damaschke NA; Gawdzik J; Avilla M; Yang B; Svaren J; Roopra A; Luo JH; Yu YP; Keles S; Jarrard DF
Clin Epigenetics; 2020 Jun; 12(1):80. PubMed ID: 32503656
[TBL] [Abstract][Full Text] [Related]
14. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk.
Tian J; Chen C; Rao M; Zhang M; Lu Z; Cai Y; Ying P; Li B; Wang H; Wang L; Li Y; Huang J; Fan L; Cai X; Ning C; Li Y; Zhang F; Wang W; Jiang Y; Liu Y; Wang M; Li H; Huang C; Yang Z; Chang J; Zhu Y; Yang X; Miao X
Cancer Res; 2022 Jun; 82(11):2084-2096. PubMed ID: 35363263
[TBL] [Abstract][Full Text] [Related]
15. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography.
Deng D; Deng G; Smith MF; Zhou J; Xin H; Powell SM; Lu Y
Nucleic Acids Res; 2002 Feb; 30(3):E13. PubMed ID: 11809901
[TBL] [Abstract][Full Text] [Related]
18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome.
Shoemaker R; Deng J; Wang W; Zhang K
Genome Res; 2010 Jul; 20(7):883-9. PubMed ID: 20418490
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific splicing effects on DKKL1 and ZNF419 transcripts in HeLa cells.
Martin G; Selcuklu SD; Schouest K; Nembaware V; McKeown PC; Seoighe C; Spillane C
Gene; 2017 Jan; 598():107-112. PubMed ID: 27826023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
